stockrow
Friday 6 November 2026
Export PRVA’s income statement to Excel — free account
Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
24.32
0.38
+1.59%
Follow PRVA
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
72.93 | 116.95 | 121.00 | 131.72 |
+8 more quarters Free account |
P/S ratio |
1.03 | 1.38 | 1.14 | 1.36 | |
P/FCF ratio |
23.30 | 24.80 | 18.55 | 17.76 | |
P/Operating CF |
86.78 | 2,950.08 | (51.63) | 22.72 | |
P/B ratio |
2.88 | 3.87 | 3.17 | 3.66 | |
Price to Tangible BV |
5.68 | 8.04 | 6.66 | 7.93 | |
EV/Sales |
0.86 | 1.21 | 0.96 | 1.15 | |
EV/EBITDA |
32.85 | 50.31 | 45.38 | 55.47 | |
EV/Operating CF |
19.40 | 21.84 | 15.69 | 14.99 | |
EV/FCF |
19.45 | 21.89 | 15.73 | 15.01 | |
Quick Ratio |
1.59 | 1.55 | 1.55 | 1.55 | |
Current Ratio |
1.63 | 1.62 | 1.61 | 1.60 | |
Net Debt/EBITDA |
(18.56) | (27.25) | (39.20) | (34.42) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.67 | 1.71 | 1.73 | 1.69 | |
Operating CF/Net income |
2.15 | 0.12 | (16.14) | 13.93 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.76% | 7.53% | 8.22% | 6.60% | |
Intangible Assets out of Total Assets |
0.28 | 0.29 | 0.30 | 0.31 | |
Share Based Compensation of Revenue |
2.14% | 3.07% | 3.63% | 2.86% | |
Graham Net Nets |
0.16 | 0.12 | 0.14 | 0.11 | |
Graham Number |
6.45 | 5.74 | 4.98 | 5.12 | |
Earnings Yield |
1.37% | 0.86% | 0.83% | 0.76% | |
Free Cash Flow Yield |
4.29% | 4.03% | 5.39% | 5.63% | |
Revenue per Share |
5.15 | 5.02 | 4.86 | 4.43 | |
Operating CF per Share |
0.23 | 0.01 | (0.40) | 1.04 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.23 | 0.01 | (0.40) | 1.04 | |
Cash per Share |
3.50 | 3.27 | 3.38 | 3.93 | |
Shareholders Equity per Share |
6.84 | 6.65 | 6.49 | 6.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.84 | 6.65 | 6.49 | 6.47 | |
Free Cash Flow |
28.94 | 1.10 | (49.46) | 127.50 | |
Working Capital |
425.20 | 390.82 | 364.72 | 342.48 | |
Net Current Asset Value |
408.76 | 374.76 | 354.03 | 332.57 | |
EV/EBIT |
41.09 | 63.83 | 59.44 | 71.52 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
49.23 | 72.31 | 70.09 | 84.62 | |
| Other line items | |||||
Average Receivables |
561.31 | 509.08 | 451.20 | 358.54 | |
Average Payables |
92.21 | 82.65 | 74.35 | 89.40 | |
Average Assets |
1,457.35 | 1,380.56 | 1,300.72 | 1,252.58 | |
Average Common Equity |
817.84 | 785.81 | 757.72 | 737.20 |
Columns are period end dates · fundamentals updated 5 Nov 2026